Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-007747
Filing Date
2025-05-14
Accepted
2025-05-14 16:08:52
Documents
93
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ganx-20250331x10q.htm   iXBRL 10-Q 1350132
2 EX-31.1 ganx-20250331xex31d1.htm EX-31.1 10965
3 EX-31.2 ganx-20250331xex31d2.htm EX-31.2 10122
4 EX-32.1 ganx-20250331xex32d1.htm EX-32.1 11606
  Complete submission text file 0001558370-25-007747.txt   7171529

Data Files

Seq Description Document Type Size
5 EX-101.SCH ganx-20250331.xsd EX-101.SCH 57440
6 EX-101.CAL ganx-20250331_cal.xml EX-101.CAL 57099
7 EX-101.DEF ganx-20250331_def.xml EX-101.DEF 211239
8 EX-101.LAB ganx-20250331_lab.xml EX-101.LAB 504724
9 EX-101.PRE ganx-20250331_pre.xml EX-101.PRE 388432
96 EXTRACTED XBRL INSTANCE DOCUMENT ganx-20250331x10q_htm.xml XML 1126170
Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Filer) CIK: 0001819411 (see all company filings)

EIN.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40237 | Film No.: 25945499
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)